Search Results - "Buracchi, Chiara"
-
1
Megakaryocytes Contribute to the Bone Marrow‐Matrix Environment by Expressing Fibronectin, Type IV Collagen, and Laminin
Published in Stem cells (Dayton, Ohio) (01-04-2014)“…Megakaryocytes associate with the bone marrow vasculature where they convert their cytoplasm into proplatelets that protrude through the vascular endothelium…”
Get full text
Journal Article -
2
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment
Published in Oncotarget (05-07-2016)“…Despite the accepted dogma that TRAIL kills only tumor cells and spares normal ones, we show in this study that mononuclear phagocytes are susceptible to…”
Get full text
Journal Article -
3
Phenotypic profiling of CD34 + cells by advanced flow cytometry improves diagnosis of juvenile myelomonocytic leukemia
Published in Haematologica (Roma) (01-02-2024)“…Diagnostic criteria for juvenile myelomonocytic leukemia (JMML) are currently well defined, however in some patients diagnosis still remains a challenge. Flow…”
Get full text
Journal Article -
4
P1361: SLEEPING BEAUTY PLATFORM FOR ENGINEERING CAR‐CIK CELLS TOWARD A MULTI‐TARGETING STRATEGY IN B‐ALL
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
5
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6
Published in Proceedings of the National Academy of Sciences - PNAS (13-02-2007)“…Fetal loss in animals and humans is frequently associated with inflammatory conditions. D6 is a promiscuous chemokine receptor with decoy function, expressed…”
Get full text
Journal Article -
6
Intestinal Inflammation in Mice Deficient in Tir8, an Inhibitory Member of the IL-1 Receptor Family
Published in Proceedings of the National Academy of Sciences - PNAS (09-03-2004)“…TIR8, also known as single lg IL-1-related receptor, is a member of the IL-1 receptor/Toll-like receptor (TLR) superfamily, which acts as an intracellular…”
Get full text
Journal Article -
7
Damping Excessive Inflammation and Tissue Damage in Mycobacterium tuberculosis Infection by Toll IL-1 Receptor 8/Single Ig IL-1-Related Receptor, a Negative Regulator of IL-1/TLR Signaling
Published in Journal of Immunology (01-09-2007)“…Toll IL-1R 8/single Ig IL-1-related receptor (TIR8/SIGIRR) is a member of the IL-1R family, expressed by epithelial tissues and immature dendritic cells, and…”
Get full text
Journal Article -
8
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
Published in Journal for immunotherapy of cancer (01-02-2021)“…BackgroundT-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease with a poor cure rate for relapsed/resistant patients. Due to the lack of T-cell…”
Get full text
Journal Article -
9
Increased inflammation in mice deficient for the chemokine decoy receptor D6
Published in European journal of immunology (01-05-2005)“…Chemokines are chemotactic cytokines with a key role in the control of cell trafficking and positioning under homeostatic and inflammatory conditions. D6 is a…”
Get full text
Journal Article -
10
Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts
Published in Stem cell reports (13-10-2015)“…Autosomal recessive osteopetrosis is a human bone disease mainly caused by TCIRG1 gene mutations that prevent osteoclasts resorbing activity, recapitulated by…”
Get full text
Journal Article -
11
The CCL3 Family of Chemokines and Innate Immunity Cooperate In Vivo in the Eradication of an Established Lymphoma Xenograft by Rituximab
Published in Journal of Immunology (15-05-2007)“…The therapeutic mAb rituximab induced the expression of the CCL3 and CCL4 chemokines in the human lymphoma line BJAB following binding to the CD20 Ag…”
Get full text
Journal Article -
12
-
13
Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities
Published in The Journal of clinical investigation (01-11-2020)“…BACKGROUNDChimeric antigen receptor (CAR) T cell immunotherapy has resulted in complete remission (CR) and durable response in highly refractory patients…”
Get full text
Journal Article -
14
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia
Published in Blood (19-01-2017)“…A fully-standardized EuroFlow 8–color antibody panel and laboratory procedure was stepwise designed to measure minimal residual disease (MRD) in B-cell…”
Get full text
Journal Article -
15
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation
Published in Leukemia (01-11-2024)Get full text
Journal Article -
16
Role of Microenvironment in Influencing the Activity of CD19 CAR T Cells in B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL)
Published in Blood (02-11-2023)“…Background: As a therapy based on immune cells, CAR T cells treatment elicits an acute response involving both innate and adaptive immunity which is followed…”
Get full text
Journal Article -
17
First Description of a Frameshift PAX5 Germline Variant in Two Siblings with B-Cell Precursor Acute Lymphoblastic Leukemia
Published in Blood (15-11-2022)Get full text
Journal Article -
18
Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges
Published in Expert review of molecular diagnostics (02-09-2018)“…Flow cytometric quantification of minimal residual disease (MRD) in acute leukemia (AL) represents an indispensable tool to guide modern therapeutic protocols…”
Get more information
Journal Article -
19
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System
Published in Molecular therapy (02-09-2020)“…The successful implementation of chimeric antigen receptor (CAR)-T cell therapy in the clinical context of B cell malignancies has paved the way for further…”
Get full text
Journal Article -
20
Single‐cell profiling of pediatric T‐cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways
Published in Cytometry. Part B, Clinical cytometry (01-11-2020)“…Background The PI3K/Akt/mTOR (PI3K) signaling pathway has a crucial role in T‐cell acute lymphoblastic leukemias (T‐ALLs). Although loss‐of‐function of…”
Get full text
Journal Article